About Novanta Inc.
https://www.novanta.comNovanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide.
CEO
Matthijs Glastra
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2010-12-29 | Reverse | 1:3 |
ETFs Holding This Stock
Summary
Showing Top 3 of 142
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:4.51M
Value:$607.89M
BLACKROCK INC.
Shares:4.41M
Value:$593.49M
VANGUARD GROUP INC
Shares:4.38M
Value:$589.84M
Summary
Showing Top 3 of 382
About Novanta Inc.
https://www.novanta.comNovanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $247.84M ▲ | $89.07M ▼ | $10.65M ▲ | 4.3% ▲ | $0.3 ▲ | $37.48M ▼ |
| Q2-2025 | $241.05M ▲ | $91.83M ▲ | $4.5M ▼ | 1.87% ▼ | $0.12 ▼ | $43.06M ▼ |
| Q1-2025 | $233.37M ▼ | $71.93M ▼ | $21.21M ▲ | 9.09% ▲ | $0.59 ▲ | $43.53M ▼ |
| Q4-2024 | $238.06M ▼ | $81.52M ▲ | $16.46M ▼ | 6.92% ▼ | $0.46 ▼ | $47.45M ▼ |
| Q3-2024 | $244.41M | $76.66M | $19.19M | 7.85% | $0.53 | $49.21M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $89.22M ▼ | $1.51B ▼ | $704.34M ▼ | $801.48M ▲ |
| Q2-2025 | $109.91M ▲ | $1.51B ▲ | $709.62M ▲ | $801.45M ▲ |
| Q1-2025 | $106.05M ▼ | $1.39B ▼ | $615.7M ▼ | $769.75M ▲ |
| Q4-2024 | $113.99M ▲ | $1.39B ▼ | $642.81M ▼ | $745.7M ▲ |
| Q3-2024 | $92.69M | $1.42B | $676.63M | $742.2M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $10.65M ▲ | $8.49M ▼ | $-5.4M ▲ | $-23.42M ▼ | $-20.69M ▼ | $4.21M ▼ |
| Q2-2025 | $4.5M ▼ | $15.07M ▼ | $-66.56M ▼ | $54.83M ▲ | $3.87M ▲ | $11.68M ▼ |
| Q1-2025 | $21.21M ▲ | $31.68M ▼ | $1.25M ▲ | $-42.73M ▼ | $-7.94M ▼ | $27.4M ▼ |
| Q4-2024 | $16.46M ▼ | $61.56M ▲ | $-2.08M ▲ | $-35.62M ▼ | $21.3M ▲ | $59.31M ▲ |
| Q3-2024 | $19.19M | $23.03M | $-3.56M | $-28.88M | $-5.78M | $19.46M |
Revenue by Products
| Product | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
 Advanced Surgery | $0 ▲ | $0 ▲ | $60.00M ▲ | $60.00M ▲ |
 Automation Enabling Technologies | $0 ▲ | $130.00M ▲ | $0 ▼ | $0 ▲ |
 Medical Solutions | $0 ▲ | $120.00M ▲ | $0 ▼ | $0 ▲ |
 Precision Manufacturing | $0 ▲ | $0 ▲ | $40.00M ▲ | $40.00M ▲ |
 Precision Medicine | $0 ▲ | $0 ▲ | $60.00M ▲ | $50.00M ▼ |
 Robotics and Automation | $80.00M ▲ | $0 ▼ | $80.00M ▲ | $80.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 CHINA | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
 GERMANY | $20.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
 Other Countries | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 Rest of Asia Pacific | $30.00M ▲ | $20.00M ▼ | $20.00M ▲ | $20.00M ▲ |
 Rest Of Europe | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $40.00M ▲ |
 UNITED STATES | $120.00M ▲ | $120.00M ▲ | $130.00M ▲ | $130.00M ▲ |
CEO
Matthijs Glastra
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2010-12-29 | Reverse | 1:3 |
ETFs Holding This Stock
Summary
Showing Top 3 of 142
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:4.51M
Value:$607.89M
BLACKROCK INC.
Shares:4.41M
Value:$593.49M
VANGUARD GROUP INC
Shares:4.38M
Value:$589.84M
Summary
Showing Top 3 of 382